查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701244

美国CT 和 MRI显影剂市场规模、份额、趋势分析报告（按模式、产品、应用、给药途径、最终用途、细分市场预测），2025-2030 年

U.S. CT And MRI Contrast Media Market Size, Share & Trends Analysis Report By Modality, By Product, By Application, By Route Of Administration, By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

美国CT 和 MRI显影剂市场的成长和趋势：

根据 Grand View Research 的新报告，美国CT 和 MRI显影剂市场规模预计到 2030 年将达到 31.7 亿美元，2025 年至 2030 年的复合年增长率为 7.23%。

这种成长是由市场参与企业之间日益激烈的竞争、研究活动的活性化以及临床试验和研究的增加所推动的。此外，行业参与者对产品核可的日益关注预计将推动未来几年的市场成长。

例如，2023年6月，拜耳公司的碘基显影剂Ultravist获得美国食品药物管理局的核准，可用于造影乳房X光摄影。 Ultravist 也适用于身体和头部的造影CT 检查，以评估成人和 2 岁及以上儿童患者中的非肿瘤性和肿瘤性病变。因此，显影剂未来几年 FDA 对 CT 和 MRI显影剂的核准增加将推动美国市场的成长。

目前，有多项临床研究正在检验显影剂在多种慢性疾病的各种 CT 和 MRI 检查中的有效性和效用。例如，麻州大学伍斯特分校正在举办一项临床试验，已招募 258 名参与者。这项临床试验正在比较两种大环钆基显影剂，钆布醇（Gadavist）和钆葡甲胺（Dotarem），用于诊断乳房疾病。该试验预计于2026年3月完成。此外，埃默里大学将于2024年7月开始针对前列腺癌患者进行标靶磁振造影显影剂的试验。如果这些临床试验取得正面成果，预计美国对CT和MRI显影剂的需求将会增加，从而促进美国市场的成长。

美国CT 和 MRI显影剂市场报告重点

  • 按方式划分，X 射线/电脑断层扫描领域在 2024 年占据了市场主导地位。然而，预计磁振造影(MRI) 领域将成长最快，预测期内的复合年增长率为 8.52%。
  • 从产品角度来看，碘显影剂领域在 2024 年占据了美国CT 和 MRI显影剂市场的主导地位。另一方面，预计钆基显影剂领域将在未来几年内实现最快成长。
  • 根据应用，神经系统疾病领域在 2024 年占据市场最大收益占有率，约 28.23%。相较之下，心血管疾病领域预计在预测期内以最高的复合年增长率成长。
  • 根据给药途径，预计静脉给药部分将在 2024 年占据美国CT 和 MRI显影剂市场的最大收益占有率，约为 52.96%。由于美国市场上产品种类繁多，预计该部分在预测期内也将以最高的复合年增长率成长。
  • 根据最终用途，医院部门占据市场主导地位，占 2024 年收入份额的 59.92%。预计该部门在预测期内成长最快。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国CT 和 MRI显影剂市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国CT与MRI显影剂市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国CT 和 MRI显影剂市场：产品评估和趋势分析

  • 定义和范围
  • 2024年及2030年的市场占有率
  • 细分仪表板
  • 美国CT 和 MRI显影剂市场展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 钆显影剂
    • 碘显影剂

第五章美国CT 和 MRI显影剂市场：模态估计和趋势分析

  • 定义和范围
  • 2024年及2030年的市场占有率
  • 细分仪表板
  • 美国CT 和 MRI显影剂市场展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 磁振造影
    • X光/电脑断层扫描

第六章美国CT和MRI显影剂市场：应用评估和趋势分析

  • 定义和范围
  • 2024年及2030年的市场占有率
  • 细分仪表板
  • 美国CT 和 MRI显影剂市场展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 心血管疾病
    • 神经系统疾病
    • 胃肠道疾病
    • 癌症
    • 肾臟疾病
    • 肌肉骨骼疾病
    • 其他的

第七章美国CT和MRI显影剂市场：给药途径估计和趋势分析

  • 定义和范围
  • 2024年及2030年的市场占有率
  • 细分仪表板
  • 美国CT 和 MRI显影剂市场展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 静脉
    • 口服显影剂
    • 直肠

第八章美国CT和MRI显影剂市场：最终用途估计和趋势分析

  • 定义和范围
  • 2024年及2030年的市场占有率
  • 细分仪表板
  • 美国CT 和 MRI显影剂市场展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 医院
    • 诊断影像中心
    • 其他的

第九章竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 主要客户
    • 2024年主要企业市场占有率分析
    • Bayer
    • GE Healthcare
    • Guerbet
    • Bracco Diagnostics Inc
    • Fresenius Kabi
Product Code: GVR-4-68040-533-6

U.S. CT and MRI Contrast Media Market Growth & Trends:

The U.S. CT and MRI contrast media market size is anticipated to reach USD 3.17 billion by 2030, expanding at a CAGR of 7.23% from 2025 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the growing competition among the market participants, rising research activities, and the increasing number of clinical trials and studies. Moreover, the rising focus of industry players on product approvals is anticipated to propel market growth in the coming years.

For instance, in June 2023, Ultravist, an iodine-based contrast agent from Bayer, received approval from the U.S. Food and Drug Administration for contrast-enhanced mammography. Ultravist is also indicated for contrast computed tomography of the body and head to evaluate non-neoplastic and neoplastic lesions in adults and pediatric patients aged 2 years and older. Thus, increasing FDA approvals of CT and MRI contrast agents is anticipated to propel the U.S. market growth in the coming years.

Currently, multiple clinical studies are examining the efficacy and utility of contrast agents in various CT and MRI examinations used for several chronic conditions. For instance, the University of Massachusetts in Worcester sponsors a clinical trial that has enrolled 258 participants. This trial compares two macrocyclic gadolinium-based contrast agents, gadobutrol (Gadavist) and gadoterate meglumine (Dotarem), for diagnosing breast diseases. The study is expected to be completed by March 2026. In addition, Emory University has been conducting a study since July 2024 to evaluate a targeted magnetic resonance imaging contrast agent in prostate cancer patients. Positive findings from these clinical studies are anticipated to increase the demand for CT and MRI contrast media in the U.S., contributing to the U.S. market growth.

U.S. CT And MRI Contrast Media Market Report Highlights:

  • Based on modality, in 2024, the x-ray/ computed tomography segment dominated the market. However, the magnetic resonance imaging (MRI) segment is anticipated to grow fastest, with a CAGR of 8.52% over the forecast period.
  • On the basis of product, the iodinated contrast media segment dominated the U.S. CT and MRI contrast media market in 2024. On the other hand, the gadolinium-based contrast media segment is anticipated to grow fastest in the coming years.
  • Based on application, the neurological disorders segment held the largest revenue share of around 28.23% in the market in 2024. In contrast, the cardiovascular disorders segment is expected to grow fastest, with the highest CAGR over the forecast period.
  • On the basis of route of administration, the intravenous segment held the largest revenue share, around 52.96%, in the U.S. CT and MRI contrast media market in 2024. This segment is also expected to grow fastest, with the highest CAGR over the forecast period due to the availability of a wide range of products in the U.S. market.
  • On the basis of the end use, the hospital segment dominated the market and accounted for a revenue share of 59.92% in 2024. This segment is also expected to grow fastest over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Modality outlook
    • 2.2.3. Application outlook
    • 2.2.4. Route of administration outlook
    • 2.2.5. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. CT and MRI Contrast Media Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing demand for medical imaging
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Side effects and potential complications associated with the use of CT MRI and contrast media
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing number of clinical trials
      • 3.2.3.2. Rising research activities
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Product recalls
  • 3.3. U.S. CT and MRI Contrast Media Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. CT and MRI Contrast Media Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. U.S. CT and MRI Contrast Media Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Gadolinium-based Contrast Media
      • 4.5.1.1. Gadolinium-based contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Iodinated Contrast Media
      • 4.5.2.1. Iodinated contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. U.S. CT and MRI Contrast Media Market: Modality Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Modality Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. U.S. CT and MRI Contrast Media Market by Modality Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Magnetic Resonance Imaging
      • 5.5.1.1. Magnetic resonance imaging market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.2. Elucirem/Vueway
        • 5.5.1.2.1. Elucirem/Vueway market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.3. Dotarem
        • 5.5.1.3.1. Dotarem market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.4. ProHance
        • 5.5.1.4.1. ProHance market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.5. MultiHance
        • 5.5.1.5.1. MultiHance market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.6. Gadovist
        • 5.5.1.6.1. Gadovist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.7. Eovist / Primovist
        • 5.5.1.7.1. Eovist / Primovist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.8. Clariscan
        • 5.5.1.8.1. Clariscan market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.9. Other Generics
        • 5.5.1.9.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. X-ray/Computed Tomography
      • 5.5.2.1. X-ray/computed tomography market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.2. Optiray
        • 5.5.2.2.1. Optiray market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.3. ISOVUE
        • 5.5.2.3.1. ISOVUE market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.4. Ultravist
        • 5.5.2.4.1. Ultravist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.5. Omnipaque
        • 5.5.2.5.1. Omnipaque market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.6. Visipaque
        • 5.5.2.6.1. Visipaque market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.7. Other Generics
        • 5.5.2.7.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. CT and MRI Contrast Media Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. U.S. CT and MRI Contrast Media Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Cardiovascular Disorders
      • 6.5.1.1. Cardiovascular disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Neurological Disorders
      • 6.5.2.1. Neurological disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Gastrointestinal Disorders
      • 6.5.3.1. Gastrointestinal disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Cancer
      • 6.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Nephrological Disorders
      • 6.5.5.1. Nephrological disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Musculoskeletal Disorders
      • 6.5.6.1. Musculoskeletal disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.7. Others
      • 6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. CT and MRI Contrast Media Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. Route of Administration Market Share, 2024 & 2030
  • 7.3. Segment Dashboard
  • 7.4. U.S. CT and MRI Contrast Media Market by Route of Administration Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Intravenous
      • 7.5.1.1. Intravenous contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Oral Contrast Media
      • 7.5.2.1. Oral contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Rectal
      • 7.5.3.1. Rectal contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. U.S. CT and MRI Contrast Media Market: End Use Estimates & Trend Analysis

  • 8.1. Definitions and Scope
  • 8.2. End Use Market Share, 2024 & 2030
  • 8.3. Segment Dashboard
  • 8.4. U.S. CT and MRI Contrast Media Market by End Use Outlook
  • 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.5.1. Hospitals
      • 8.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.2. Diagnostic Imaging Centers
      • 8.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.3. Others
      • 8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Bayer
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. GE Healthcare
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Guerbet
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Bracco Diagnostics Inc
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Fresenius Kabi
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. U.S. CT and MRI contrast media market, by modality 2018 - 2030 (USD Million)
  • Table 4. U.S. CT and MRI contrast media market, by product 2018 - 2030 (USD Million)
  • Table 5. U.S. CT and MRI contrast media market, by application, 2018 - 2030 (USD Million)
  • Table 6. U.S. CT and MRI contrast media market, by end-use 2018 - 2030 (USD Million)
  • Table 7. U.S. CT and MRI contrast media market, by route of administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. CT and MRI contrast media market: Market snapshot
  • Fig. 9 U.S. CT and MRI contrast media market: Market segmentation
  • Fig. 10 U.S. CT and MRI contrast media market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 U.S. CT and MRI contrast media market driver impact
  • Fig. 14 U.S. CT and MRI contrast media market restraint impact
  • Fig. 15 U.S. CT and MRI contrast media market porter's five forces analysis
  • Fig. 16 U.S. CT and MRI contrast media market PESTEL analysis
  • Fig. 17 U.S. CT and MRI contrast media market segment dashboard
  • Fig. 18 U.S. CT and MRI contrast media market: Product movement Analysis
  • Fig. 19 Gadolinium-based contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Iodinated contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. CT and MRI contrast media market: Modality movement Analysis
  • Fig. 22 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 X-ray/computed tomography market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. CT and MRI contrast media market: Application movement Analysis
  • Fig. 25 Cardiovascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Nephrological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Musculoskeletal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. CT and MRI contrast media market: Route of administration movement Analysis
  • Fig. 32 Intravenous market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Oral contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Rectal contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. CT and MRI contrast media market: End use movement Analysis
  • Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Diagnostic imaging centers contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)